Cytomegalovirus Retinitis Study Group

The Cytomegalovirus Retinitis Study Group is a research organization dedicated to understanding and improving treatment for cytomegalovirus (CMV) retinitis, an eye infection that can cause blindness, especially in people with weakened immune systems like those with AIDS. They conduct studies to evaluate the effectiveness and safety of antiviral medications, aiming to enhance patient outcomes. Their work helps guide clinical practices, ensuring patients receive effective therapies to protect vision from this potentially devastating infection.